A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
DexCom, Inc. DXCM
Strong Health Tech sector · Continuous glucose monitors — recurring sensor revenue as diabetes care goes wearable.
Key quality signals
Revenue growth (YoY)16.1%
Gross margin61.8%
Gross profits / assets0.45
Rule of 4037.5
Net margin21.4%
Cash runway (months)—
PEG0.4
P/S6.3
Insider & analyst context
- Insider 90-day: 0 cluster buyer(s), 4 seller(s). Insider selling is routine diversification, not a bearish signal.
- Analyst mix: 15 strong-buy / 17 buy / 5 hold / 0 sell. Ratings are context, not a price target.
Similar Health Tech names
← All Health Tech names · Open DXCM in the interactive screener →
Data as of 2026-06-09 22:43 (end-of-day). How grades are computed →